Results 1 to 10 of about 2,052,006 (381)

EXPERIMENTAL CIRRHOSIS OF THE LIVER [PDF]

open access: bronzeThe American Journal of the Medical Sciences, 1906
The reparative process which follows the wide spread necrosis of the dog's liver caused by the injection of hæmagglutinative serum constitutes a chronic interstitial hepatitis of definite and constant character. This is not only a new type of experimental hepatic lesion, but is more definitely a cirrhosis than is any other experimental lesion hitherto ...
Richard M. Pearce
openalex   +7 more sources

Serum microRNA-122 predicts survival in patients with liver cirrhosis [PDF]

open access: yes, 2012
Background: Liver cirrhosis is associated with high morbidity and mortality. MicroRNAs (miRs) circulating in the blood are an emerging new class of biomarkers.
Brunner, Friederike   +5 more
core   +8 more sources

Irisin in Liver Cirrhosis [PDF]

open access: yesJournal of Clinical Medicine, 2020
Background: Sarcopenia is a prevalent muscle abnormality characterized by progressive and generalized loss of skeletal muscle mass and strength, common among patients with decompensated advanced chronic liver disease (dACLD). Irisin is a recently identified myokine, which is mainly expressed and secreted by skeletal muscle.
Michał Kukla   +12 more
openaire   +4 more sources

Computed Tomography Images of Spontaneous Portosystemic Shunt in Liver Cirrhosis

open access: yesCanadian Journal of Gastroenterology and Hepatology, 2022
Spontaneous portosystemic shunt (SPSS) refers to collateral vessels that communicate between the portal vein system and systemic circulation. SPSS mainly includes esophageal varices, gastric varices, left gastric vein, recanalized paraumbilical vein ...
Fangfang Yi   +7 more
doaj   +1 more source

No Association of Homocysteine, Anticardiolipin Antibody, and Anti-β2 Glycoprotein I Antibody With Portal Venous System Thrombosis in Liver Cirrhosis

open access: yesClinical and Applied Thrombosis/Hemostasis, 2021
Portal venous system thrombosis (PVST), a common complication of liver cirrhosis, is closely associated with thrombophilia. To explore the association of homocysteine (Hcy), anticardiolipin antibody (aCL), and anti-β2 glycoprotein I antibody (aβ 2 GPI ...
Le Wang   +8 more
doaj   +1 more source

Identification of novel non-HFE mutations in Chinese patients with hereditary hemochromatosis

open access: yesOrphanet Journal of Rare Diseases, 2022
Backgrounds Hereditary hemochromatosis (HH) is mainly caused by homozygous p.C282Y mutations in HFE in the Caucasians. We recently reported non-HFE mutations constitute the major cause of HH in Chinese.
Wei Zhang   +17 more
doaj   +1 more source

Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China

open access: yesOrphanet Journal of Rare Diseases, 2021
Background Hereditary hemochromatosis (HH) is widely recognized and clinical manifestations of hemochromatosis-related (HFE-related) HH is well studied in European populations.
Liyan Wu   +17 more
doaj   +1 more source

CO2 or air cholangiography reduces the risk of post-ERCP cholangitis in patients with Bismuth type IV hilar biliary obstruction

open access: yesBMC Gastroenterology, 2020
Background Endoscopic biliary stenting by endoscopic retrograde cholangiopancreatography (ERCP) is the most common form of palliation for malignant hilar obstruction. However, ERCP in such cases is associated with a risk of cholangitis.
Wen-hui Zhang   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy